Hims & Hers Health Files 8-K

TL;DR

HIMS filed an 8-K on May 9th for an event on May 8th, mostly financial exhibits.

AI Summary

Hims & Hers Health, Inc. filed an 8-K on May 9, 2025, reporting an event that occurred on May 8, 2025. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text.

Why It Matters

This filing indicates routine corporate reporting, likely related to financial disclosures or exhibit submissions, which are standard for publicly traded companies.

Risk Assessment

Risk Level: low — The filing appears to be routine and does not disclose any new material risks or significant negative events.

Key Players & Entities

• Hims & Hers Health, Inc. (company) — Registrant
• Oaktree Acquisition Corp. (company) — Former Company Name
• May 8, 2025 (date) — Earliest event reported date
• May 9, 2025 (date) — Date of Report

FAQ

From the Filing

0001193125-25-116439.txt : 20250509 0001193125-25-116439.hdr.sgml : 20250509 20250509070017 ACCESSION NUMBER: 0001193125-25-116439 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250508 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250509 DATE AS OF CHANGE: 20250509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 25928307 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 8-K 1 d905005d8k.htm 8-K 8-K false 0001773751 0001773751 2025-05-08 2025-05-08     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025     HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter)       Delaware   001-38986   98-1482650 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   2269 Chestnut Street, #523 San Francisco , CA 94123 (Address of principal executive offices) (415) 851-0195 (Registrant’s telephone number, including area code)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol   Name of each exchange on which registered Class A Common Stock, $0.0001 par value   HIMS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01. Other Events. On May 8, 2025, Hims & Hers Health, Inc. (the “ Company ”) issued a press release relating to its proposed private offering of Convertible Senior Notes due 2030 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “ Securities Act ”). A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this Item 8.01. On May 8, 2025, the Company issued a press release relating to the pricing of its private offering of 0.00% Convertible Senior Notes due 2030 (the “ Notes ”) to q